# AMOXICILLIN AND CLAVULANATE POTASSIUM
> **ANDA209991** · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2023-09-15
## Drug
- **FDA Application Number:** ANDA209991
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Generic name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Active ingredients:** AMOXICILLIN; CLAVULANATE POTASSIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DEVA HOLDING AS
- **Manufacturer:** Devatis, Inc.
- **First approval:** 2023-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209991)
---
*AI Analytics · CC0 1.0*